Overall, the literature surrounding the role of IL-18 in AMD indicates a potential dual role of this pro-inflammatory cytokine in modulating retinal damage in neovascular retinal diseases including wet AMD, which may act differently to its involvement in dry AMD pathogenesis. Here, IL18 is linked to wet macular degeneration.